Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Richter

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 11, 2021
Financial toxicity in sarcoma patients and survivors in Germany: results from the multicenter PROSa studyMatthias Büttner, Susanne Singer, Leopold Hentschel, et al.
Cancers|February 10, 2024
Geriatric Assessment of Older Patients Receiving Trabectedin in First-Line Treatment for Advanced Soft Tissue Sarcomas: The E-TRAB Study from The German Interdisciplinary Sarcoma Group (GISG-13)Bernd Kasper, Daniel Pink, Christian Rothermundt, et al.
Therapeutic Advances in Neurological Disorders|January 27, 2025
Vaccination coverage and its determinants in patients with multiple sclerosis-a multicenter cross-sectional studyPaula Schade, Hai-Anh Nguyen, Julia Steinle, et al.
Journal of Cancer Research and Clinical Oncology|January 9, 2023
Working situation and burden of work limitations in sarcoma patients: results from the multi-center prospective PROSa studySergio Armando Zapata Bonilla, Marius Fried, Susanne Singer, et al.
Psycho-Oncology|August 11, 2022
Distress in soft-tissue sarcoma and gastrointestinal stromal tumours patients-Results of a German multicentre observational study (PROSa)Martin Eichler, Leopold Hentschel, Susanne Singer, et al.
Oncology Research and Treatment|January 15, 2025
Preferences on Treatment Decision Making in Sarcoma Patients: Prevalence and Associated Factors - Results from the PROSa StudyHanna Salm, Markus K Schuler, Leopold Hentschel, et al.
Cancers|December 30, 2025
Refining Risk Stratification and Surveillance Strategies in Pleuropulmonary Solitary Fibrous Tumors-An International, Retrospective, Multicenter AnalysisRahel S Decker, Daniel Baum, Stephan Richter, et al.
European Journal of Cancer (Oxford, England : 1990)|March 24, 2018
The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 'CREATE'Patrick Schöffski, Agnieszka Wozniak, Michael G Leahy, et al.
BMJ Open|August 30, 2020
Quality of life and added value of a tailored palliative care intervention in patients with soft tissue sarcoma undergoing treatment with trabectedin: a multicentre, cluster-randomised trial within the German Interdisciplinary Sarcoma Group (GISG)Leopold Hentschel, Stephan Richter, Hans-Georg Kopp, et al.
BMC Neurology|January 20, 2017
Electrocardiographic assessments and cardiac events after fingolimod first dose - a comprehensive monitoring studyVolker Limmroth, Tjalf Ziemssen, Michael Lang, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 11, 2021
Financial toxicity in sarcoma patients and survivors in Germany: results from the multicenter PROSa studyMatthias Büttner, Susanne Singer, Leopold Hentschel, et al.
Cancers|February 10, 2024
Geriatric Assessment of Older Patients Receiving Trabectedin in First-Line Treatment for Advanced Soft Tissue Sarcomas: The E-TRAB Study from The German Interdisciplinary Sarcoma Group (GISG-13)Bernd Kasper, Daniel Pink, Christian Rothermundt, et al.
Therapeutic Advances in Neurological Disorders|January 27, 2025
Vaccination coverage and its determinants in patients with multiple sclerosis-a multicenter cross-sectional studyPaula Schade, Hai-Anh Nguyen, Julia Steinle, et al.
Journal of Cancer Research and Clinical Oncology|January 9, 2023
Working situation and burden of work limitations in sarcoma patients: results from the multi-center prospective PROSa studySergio Armando Zapata Bonilla, Marius Fried, Susanne Singer, et al.
Psycho-Oncology|August 11, 2022
Distress in soft-tissue sarcoma and gastrointestinal stromal tumours patients-Results of a German multicentre observational study (PROSa)Martin Eichler, Leopold Hentschel, Susanne Singer, et al.
Oncology Research and Treatment|January 15, 2025
Preferences on Treatment Decision Making in Sarcoma Patients: Prevalence and Associated Factors - Results from the PROSa StudyHanna Salm, Markus K Schuler, Leopold Hentschel, et al.
Cancers|December 30, 2025
Refining Risk Stratification and Surveillance Strategies in Pleuropulmonary Solitary Fibrous Tumors-An International, Retrospective, Multicenter AnalysisRahel S Decker, Daniel Baum, Stephan Richter, et al.
European Journal of Cancer (Oxford, England : 1990)|March 24, 2018
The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 'CREATE'Patrick Schöffski, Agnieszka Wozniak, Michael G Leahy, et al.
BMJ Open|August 30, 2020
Quality of life and added value of a tailored palliative care intervention in patients with soft tissue sarcoma undergoing treatment with trabectedin: a multicentre, cluster-randomised trial within the German Interdisciplinary Sarcoma Group (GISG)Leopold Hentschel, Stephan Richter, Hans-Georg Kopp, et al.
BMC Neurology|January 20, 2017
Electrocardiographic assessments and cardiac events after fingolimod first dose - a comprehensive monitoring studyVolker Limmroth, Tjalf Ziemssen, Michael Lang, et al.
Pageof 7